- Research article
- Open Access
Crystal structure of the γ-hydroxymuconic semialdehyde dehydrogenase from Pseudomonas sp. strainWBC-3, a key enzyme involved in para-Nitrophenol degradation
BMC Structural Biologyvolume 13, Article number: 30 (2013)
para-Nitrophenol (PNP) is a highly toxic compound with threats to mammalian health. The pnpE-encoded γ-hydroxymuconic semialdehyde dehydrogenase catalyzes the reduction of γ-hydroxymuconic semialdehyde to maleylacetate in Pseudomonas sp. strain WBC-3, playing a key role in the catabolism of PNP to Krebs cycle intermediates. However, the catalyzing mechanism by PnpE has not been well understood.
Here we report the crystal structures of the apo and NAD bound PnpE. In the PnpE-NAD complex structure, NAD is situated in a cleft of PnpE. The cofactor binding site is composed of two pockets. The adenosine and the first ribose group of NAD bind in one pocket and the nicotinamide ring in the other.
Six amino acids have interactions with the cofactor. They are C281, E247, Q210, W148, I146 and K172. Highly conserved residues C281 and E247 were identified to be critical for its catalytic activity. In addition, flexible docking studies of the enzyme-substrate system were performed to predict the interactions between PnpE and its substrate γ-hydroxymuconic semialdehyde. Amino acids that interact extensively with the substrate and stabilize the substrate in an orientation suitable for enzyme catalysis were identified. The importance of these residues for catalytic activity was confirmed by the relevant site-directed mutagenesis and their biochemical characterization.
para-Nitrophenol (PNP), which is widely used in the manufacture of medicines, pesticides, dyes, explosives, leather coloring, wood preservatives and rubber chemicals, is highly toxic to animal’s health. Through the respiratory system and skin it affects the blood, liver and central nervous system in the body. It can cause dizziness, rash, itching spam, anemia and various neurological symptoms . It contains a nitroso group in the structure that strongly attracts the electron of phenyl, thus PNP is difficult for degradation in the nature .Therefore, a number of studies have been triggered focusing on the microbial degradation of PNP [3–6] and two pathways have been clearly illustrated so far. One is the hydroquinone pathway that is usually found in Gram-negative bacteria. For example, in Moraxella sp, PNP monooxygenase converts PNP to hydroquinone via the potential intermediate p-benzoquinone [7, 8]. The other is the hydroxyquinol (1, 2, 4-trihydroxybenzene) pathway that is preferentially found in Gram-positive bacteria. For example, in Rhodococcus opacus SAO101, PNP is converted to hydroxyquinol via 4-nitrocatechol [9, 10].
Pseudomonas sp. strain WBC-3 utilizes either methyl parathion (O,O-dimethyl O-p-nitrophenol phosphorothioate) or PNP as the sole source of carbon, nitrogen and energy for survival . This bacterium degrades PNP through the hydroquinone pathway. First, PNP is converted to p-benzoquinone by PNP 4-monooxygenase (PnpA) and p-benzoquinoneis further reduced to hydroquinone by p-benzoquinone reductase (PnpB). Next, hydroquinone dioxygenase (PnpCD) converts hydroquinone to γ-hydroxymuconic semialdehyde, which is then converted to maleyacetate by the NAD dependent γ-hydroxymuconic semialdehyde dehydrogenase (PnpE). Finally, maleylacetate reductase (PnpF) catalyzes the conversion of maleyacetate to β-ketoadipate before entering the TCA cycle.
In contrast to the reasonably thorough biochemical and genetic characterization of the PNP degradation, the structural mechanism of each reaction step in the pathway remains unclear. In order to understand the structural basis required for the activity of the enzyme, we embarked on structure determination of these enzymes that catalyze the PNP degradation process.
Recently, the primary X-ray analysis of PnpA in P.putida DLL-E4 was reported. In which PnpA was crystallized and the diffraction data was obtained . However, there was no further structural report about the enzyme or other molecules involved in the hydroquinone pathway. PnpE belongs to NAD dependent aldehyde dehydrogenase (ALDH) super-family which can catalyze the aldehydes oxidation to corresponding carboxylic acids [13–15]. To date, some crystal structures of NAD (P) + - dependent ALDH family have been reported [16–20]. These enzymes exhibit wide differences in substrate and cofactor specificity. Sequence alignments of them with PnpE gave amino acid sequence identities ranging from 23% to 45%. Among them mitochondrial aldehyde dehydrogenase from bovine gives the highest sequence identity with PnpE.
This super family involves highly conserved residues Cys which was essential nucleophile and Glu that was the general base necessary to activate Cys for the dehydrogenase reaction. The substrate of PnpE is γ-hydroxymuconic semialdehyde which is unstable in air. So far the catalytic mechanism of this substrate has not been reported. In the current study, we determined the crystal structure of Pseudomonas sp. strain WBC-3 apo-PnpE at 2.7 Å resolution and its complex with NAD at 3.1 Å resolution. Through enzyme-substrate docking-guided point mutations, we identified the active site of PnpE and studied its catalytic mechanism.
Bacterial strains, chemicals, media and culture conditions
Pseudomonas sp. Strain WBC-3 genomic DNA obtained from Wu Han Institute of Virology, Chinese Academy of Science. Escherichia coli strain BL21(DE3) used as expression host, which was cultured at 37°C in lysogeny broth (LB) and transformed as described by Sambrooket al. . All chemical products used in the experiment were purchased from Sigma Chemical Co. (St Louis, MO, USA).
Gene cloning and oligonucleotide-directed mutagenesis sequencing
pnpE gene from Pseudomonas sp. strain WBC-3 was cloned into NdeI and XhoI sites of pET29b (Novagen). Nine PnpE mutants (C281A, E247K, F150A, W157A, H275E, F447A, N149A, F154A, I282D) were produced using the two-step PCR strategy  and were confirmed by DNA sequencing.
Protein expression and purification
The E.coli cells were cultured in the LB medium containing 100 μg/mL ampicillin until OD600 reached 0.8 and were then induced with 1 mM IPTG overnight at 15°C. The cells were harvested by centrifugation. Cells lysis was achieved by sonication method. After centrifugation at 28,000 × g for 45 min, the supernatant was applied to Ni-NTA column. The His-tagged PnpE was eluted with elution buffer (10 mM Tris–HCl pH 8.0, 100 mM NaCl, and 250mM imidazole). The purification process was then followed by anion exchange on a Source-Q column and finally applied to size-exclusion chromatography with Superdex-200 column.
Enzyme activity assays
The catalytic activity of PnpE was measured by cascade reactions. The biosynthesis of γ-hydroxymuconic was performed in a total volume of 100 μL system containing 0.1 mM hydroquinone, 5.6μg hydroquinone dioxygenase PnpCD (PnpCD was expressed and purified in the same way as described in section 2.3) and 0.1 mM FeSO4 and 100mM Tris–HCl (pH 8.0) at 25°C. The absorbance of the reaction mixture was monitored at 290 nm until no further decrease was observed (about 10 min). At this point, the product solution can be used as the substrate for the next step to test PnpE activity. The assay of PnpE was performed immediately after the production of γ-hydroxymuconic in 100μL reaction system containing 5.2 μg purified PnpE, 10 μL γ-hydroxymuconic (produced by biosynthesis method), 0.1 mM NAD and 100 mM Tris–HCl (pH 8.0). The reaction was incubated at 25°C for 15 min. PnpE activity was determined by measuring the absorbance increase at 340 nm due to NADH formation.
Crystallization and data collection
Protein concentration was adjusted to 10 mg/mL before setting up crystallization screens at 20°C. Initially the native crystals were grown from 20% (w/v) PEG3350, 0.2 M KNO3 at 20°C using the sitting-drop, vapor-diffusion technique. The crystallization condition for the NAD bound PnpE was 0.1 M Bicine pH 8.5, 20% PEG10000 and 1 mM NAD. Both data of the two kinds of crystals were collected on BL17U beam line at the Shanghai Synchrotron Radiation Facility (Shanghai, China) using a MAR 225 CCD detector. Crystals were equilibrated in a cryoprotection buffer containing 15% glycerol (v/v) plus reservoir buffer and then flash frozen in a 100K nitrogen stream. The diffraction images were processed with HKL2000 .
Structure determination and refinement
The crystal structure was solved by molecular replacement methods using the program Phaser of the CCP4 program suite  with bovine mitochondrial aldehyde dehydrogenase (PDB code: 1A4Z)  as the search model. The initial phase obtained from molecular replacement was further refined using PHENIX . The model was rebuilt using COOT . Data collection and structure refinement statistics are summarized in Table 1. All the molecular graphics figures were generated with PyMol (http://www.pymol.org). The apo and complex structures have been deposited in the Protein Data Bank with access codes of 4GO3 and 4GO4.
Flexible docking of substrate to PnpE
AUTODOCK 4.2  was used to carry out the PnpE-substrate flexible docking. Three out of the nine bonds of the substrate molecule γ-hydroxymuconic semialdehyde were set rotatable. A grid box with sufficient margins (40 × 36 × 36 Å), which enveloped the potential active region of PnpE, was placed to restrain the substrate molecule. This potential active region was implicated by the structure of E.coli L-Lactaldehyde dehydrogenases (PDB code: 2imp) , which is homologous with PnpE. In the active region of PnpE, 9 residues (C281, E247, N149, F150, F154, W157, H275, F447, I282) were assigned as flexible. A genetic search algorithm  was used for the docking and a total of 2,500,000 steps of energy evaluations were performed during the docking. Finally, the first ranked docking result according to the interaction energy was chosen as the result. The flexible docking was performed on a 12-core computer station, which consists of Intel Itanium2 Dual Core running at 1.6 GHz. The average wall clock for one docking run was about 2 hours.
Results and discussion
Overall structure of apo-PnpE
The crystal belongs to space group P21. The asymmetric unit contains eight monomers named A, B, C, D, E, F, G and H which form four homodimers (Figure 1A). The monomer of PnpE has the typical structural organization βαβ of the ALDH family, with 17 β-strands (β1-β17) and 14 α-helices (α1-α14) (Figure 1B). These secondary structures belong to three domains (Figure 1C): a substrate binding domain, a cofactor binding domain, and an oligomerization domain mediating protein dimerization.
The substrate binding domain consists of a central six-stranded β-sheet (β11 to β16) and six α-helices (α8 to α13), while the cofactor binding domain contains a nine-stranded β-sheet (β1-β4) (β6-β10) and seven α-helices (α1-α7) (Figure 1B).
The four homodimers show high structural similarities. Structure comparisons between AC and other three homodimmers give root mean square deviation (rmsd) values of 0.267 Å, 0.326 Å and 0.214 Å for Cα respectively. The dimer interface consists of β5 (residues F130 to K137), β17 (E469 to N476), loop1 (D117 to F130) and loop2 (V477 to R487) (Figure 1B). Loop1 connects β5 and α3. Loop2 is sited in the C terminal. The interface area of the PnpE monomer for dimerization is 3228.7 Å.
Among all the structure-known homologues of PnpE, the bovine aldehyde dehydrogenase  shares the highest sequence identity (45%) with PnpE. The human aldehyde dehydrogenase  follows close behind with a sequence identity of 44%. The result of sequence alignment indicates these proteins may share similar structures. Structure superimposition shows bovine aldehyde dehydrogenase has a rmsd of 0.925 Å for Cα with PnpE, meanwhile the Cα rmsd between human aldehyde dehydrogenase and PnpE is 0.943 Å.
Structure of PnpE-NAD complex
There are also eight PnpE-NAD complexes in asymmetric unit. NAD molecule was found in all PnpE monomers (Figure 2A). The cofactor binding domain of PnpE is gathered together like a clamp that can hold the NAD (Figure 2B).
In the PnpE-NAD complex structure, NAD is situated in a cleft of PnpE. The cofactor binding site is composed of two pockets. The adenosine and the first ribose group of NAD bind in one pocket and the nicotinamide ring in the other. There are several hydrogen bond interactions between PnpE and NAD. The adenine N1A amino group of NAD forms a hydrogen bond with OE1 of Q210 of PnpE. The ribose hydroxyl groups O2B and O3B receive hydrogen bonds from the side chain of K172 and V146, respectively. The diphosphate O2N donates a hydrogen bond to W148. The C4N accepts a hydrogen bond from C281. N7N accepts a hydrogen bond from E247 (Figure 2C).
The PnpE structure of the PnpE-NAD complex is quite similar to apo-PnpE with a Cα rmsd of 0.52 Å. The most significant structural discrimination is observed at the loop between L246 and G252, in which the spatial position of the E247 moved 4.87 Å. This segment belongs to NAD binding region. In the apo-PnpE structure, this loop blocks the NAD binding site. In the complex structure, however, it moves to open the binding site to create enough space for NAD binding (Figure 2C).
Structural bases for the specificity of cofactor binding
So far, both NAD and NADP have been known to be cofactors of the ALDH family. PnpE specifically uses NAD as cofactor. In order to elucidate the structural basis for the coenzyme specificity of PnpE, we compared structures of PnpE-NAD and NADP bound Betaine Aldehyde Dehydrogenase (BADH) (PDB code: 2wme) from Pseudomonas Aeruginosa  (Figure 3). Among NADP dependent proteins with known structures, BADH shares the highest sequence identity of 41% with PnpE. Since the only difference between NAD and NADP is that the later has an extra phosphate group, PnpE and BADH should be able to distinguish them by this point. Both PnpE and BADH contain a two-pocket NAD (P) binding site. The first pocket is close to the molecule surface and accommodates the adenosine moiety of NAD, whereas the second, which is deeply located in the active site, can accommodate the nicotinamide ribose moiety. From the structures we can see clearly that the second pocket of BADH is wider than that of PnpE. This means BADH has extra space to accommodate the phosphate group of NADP whereas PnpE does not. On the other hand, in BADH the cofactor bind pocket surface around phosphate group is highly positive charged to match the negative charge of the phosphate group. This is not the case in PnpE. Therefore, PnpE can only use NAD rather than NADP as its cofactor.
Molecular docking results and mutagenesis analysis
The substrate γ-hydroxymuconic semialdehyde for PnpE contains an enol structure, which tends to convert into keto under aerobic condition. So it is impracticable to get holo-PnpE structure. To figure out the catalytic mechanism of PnpE without holo-PnpE structure we performed flexible docking for NAD bound PnpE and γ-hydroxymuconic semialdehyde using AUTODOCK (experimental procedure detailed in section 2.7). The docking result is illustrated in Figure 4. The substrate located in a narrow cleft close to NAD. There are nine residues (C281, E247, F150, I282, F154, H275, F447, W157, N149) probably involved in the substrate binding. C281 forms hydrogen bond with the aldehyde group of the substrate directly and may play a key role in the enzymatic reaction. F150, F154, F447, W157, N149, I282 and H275 probably composed a hydrophobic pocket to accommodate the substrate. However, W157 and F447 are a little farther from the substrate compared to other five residues.
To confirm the molecular docking result, nine single amino acid mutants (C281A, E247K, N149D, F150A, F154A, W157A, H275E, F447A, I282D) were generated using a two-step PCR strategy. Their enzyme activities were then measured and repeated four times (Figure 5). The results showed the mutants of C281A, E247K, N149D, F150A, H275E and I282D completely lost their activity. The activity of F154A decreased about 60%. The activity of W157Aand F447A decreased about 20%. C281 and E247, which are highly conserved across the ALDH family members, have been known to play essential roles in the catalytic process. The loss of PnpE activity by N149D, F150A, H275E, I282D, and the significant decrease of the activity by F154A also argue that these amino acids play important roles in the substrate binding. W157 and F447 do not contact substrate directly, thus W157A and F447A only affected enzymatic activity modestly, compared to the significant effects of other seven mutations. These data are consistent with the result of AUTODOCK calculations.
Sequence-based alignment of PnpE and previously determined structures of ALDHs shows that two residues (E247 and C281) are highly conserved across different species (Figure 6). These two amino acids act as the catalytic residues that transport electron, according to the mechanism elucidated in other homologous proteins [30–32]. In this regard, PnpE may have a similar catalytic mechanism (Figure 7). The catalytic C281 plays a role as a nucleophilic reagent. It attacks the hydroxymuconic semialdehyde substrate and forms a covalent intermediate. Next, the hydride from this intermediate transfers to NAD to form NADH and the thioacyl enzyme intermediate. The other catalytic residue E247 directly attacks the acyl-sulfur bond and releases the acid product prior to NADH dissociation.
The atomic coordinates and structure factors have been deposited under the accession codes: 4GO3 and 4GO4 in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
Kohring S, Wiegel J, Mayer F: Subunit composition and glycosidic Activities of the Cellulase Complex from Clostridium thermocellum JW20. Appl Environ Microbiol 1990, 56(12):3798–3804.
Hotchkiss SA, Hewitt P, Caldwell J, Chen WL, Rowe RR: Percutaneous absorption of nicotinic acid, phenol, benzoic acid and triclopyr butoxyethyl ester through rat and human skin in vitro: further validation of an in vitro model by comparison with in vivo data. Food Chem Toxicol 1992, 30(10):891–899. 10.1016/0278-6915(92)90056-Q
Munnecke DM, Hsieh DP: Microbial decontamination of parathion and p-nitrophenol in aqueous media. Appl Microbiol 1974, 28(2):212–217.
Ramadan MA: A variable response of degrading bacteria to phosphorus added to natural water. J Appl Bacteriol 1994, 76(4):314–319. 10.1111/j.1365-2672.1994.tb01634.x
Thouand G, Friant P, Bois F, Cartier A, Maul A, Block JC: Bacterial inoculum density and probability of para-nitrophenol biodegradability test response. Ecotoxicol Environ Saf 1995, 30(3):274–282. 10.1006/eesa.1995.1031
Spain JC, Gibson DT: Pathway for Biodegradation of p-Nitrophenol in a Moraxella sp. Appl Environ Microbiol 1991, 57(3):812–819.
Spain JC, Wyss O, Gibson DT: Enzymatic oxidation of p-nitrophenol. Biochem Biophys Res Commun 1979, 88(2):634–641. 10.1016/0006-291X(79)92095-3
Jain RK, Dreisbach JH, Spain JC: Biodegradation of p-nitrophenol via 1,2,4-benzenetriol by an Arthrobacter sp. Appl Environ Microbiol 1994, 60(8):3030–3032.
Kitagawa W, Kimura N, Kamagata Y: A novel p-nitrophenol degradation gene cluster from a gram-positive bacterium, Rhodococcus opacus SAO101. J Bacteriol 2004, 186(15):4894–4902. 10.1128/JB.186.15.4894-4902.2004
Chen Y, Zhang X, Liu H, Wang Y, Xia X: Study on Pseudomonas sp. WBC-3 capable of complete degradation of methylparathion. Wei Sheng Wu Xue Bao 2002, 42: 490–497.
Zhang J-J, Liu H, Xiao Y, Zhang X-E, Zhou N-Y: Identification and characterization of catabolic para-Nitrophenol 4-Monooxygenase and para-Benzoquinone Reductase from Pseudomonas sp. Strain WBC-3. Jounal of Bacteriology 2009, 191(8):2703–2710. 10.1128/JB.01566-08
Liu W, Shen W, Zhao X, Cao H, Cui Z: Expression, purification, crystallization and preliminary X-ray analysis of para-nitrophenol 4-monooxygenase from Pseudomonas putida DLL-E4 Acta Crystallographica Section F Structural Biology and Crystallization. Communications 2009, 65: 1004–1006.
Sophos NA, Vasiliou V: Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 2003, 143–144: 5–22.
Hempel J, Nicholas H, Lindahl R: Aldehyde dehydrogenases: widespread structural and functional diversity within a shared framework. Protein Sci 1993, 2(11):1890–1900. 10.1002/pro.5560021111
Ziegler TL, Vasiliou V: Aldehyde dehydrogenase gene superfamily. The 1998 update. Adv Exp Med Biol 1999, 463: 255–263.
Steinmetz CG, Xie P, Weiner H, Hurley TD: Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure 1997, 5(5):701–711. 10.1016/S0969-2126(97)00224-4
Moore SA, Baker HM, Blythe TJ, Kitson KE, Kitson TM, Baker EN: Sheep liver cytosolic aldehydedehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehydedehydrogenases. Structure 1998, 6: 1541–1551. 10.1016/S0969-2126(98)00152-X
Cobessi D, Tete-Favier F, Marchal S, Azza S, Branlant G, Aubry A: Apo and holo crystal structure of an NADP-dependent aldehyde dehydrogenase from Streptococcus mutans. J Mol Biol 1999, 290: 161–173. 10.1006/jmbi.1999.2853
Cobessi D, Tete-Favier F, Marchal S, Branlant G, Aubry A: Structural and biochemical investigations of the catalytic mechanism of an NADP dependent aldehyde dehydrogenase from Streptococcus mutans. J Mol Biol 2000, 300: 141–152. 10.1006/jmbi.2000.3824
Perez-Miller SJ, Hurley TD: Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry 2003, 42(23):7100–7109. 10.1021/bi034182w
Sambrook J, Fritsch EF, Maniatis T (Eds): Molecular cloning: a laboratory manual. 2nd edition. NY: Cold Spring Harbor Laboratory Press; 1989.
Herlitze S, Kuenen M: A general and rapid mutagenesis method using polymerase chain reaction. Gene 1990, 91: 143–147. 10.1016/0378-1119(90)90177-S
Otwinowski Z, Minor W: Macromolecular crystallography. Methods Enzymol 1997, 276: 307–326.
Winn MD: Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 2011, D67: 760–763.
Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Read RJ, Sacchettini JC, Sauter NK, Terwilliger TC: Phenix: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 2002, 58: 1948–1954. 10.1107/S0907444902016657
Emsley P, Cowtan K: Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004, 60: 2126–2132. 10.1107/S0907444904019158
MORRIS GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ: Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Computational Chemistry 1998, 19: 1639–1662. 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
Costanzol D, Gomez GA, Christianson DW: Crystal structure of lactaldehyde dehydrogenase from Escherichia coli and inferences regarding substrate and cofactor specificity. J Mol Biol 2007, 366(2):481–493. 10.1016/j.jmb.2006.11.023
Gonzalez-Segura L, Rudino-Pinera E, Munoz-Clares RA, Horjales E: The crystal structure of a ternary complex of betaine aldehyde dehydrogenase from Pseudomonas aeruginosa provides new insight into the reaction mechanism and shows a novel binding mode of the 2′-phosphate of NADP + and a novel cation binding site. J Mol Biol 2009, 385(2):542–557. 10.1016/j.jmb.2008.10.082
Ni L, Zhou J, Huriev TD, Weiner H: Human liver mitochondrial aldehyde dehydrogenase: three-dimensional structure and the restoration of solubility and activity of chimeric forms. Protein Sci 1999, 8(12):2784–2790.
Tsybovsky Y, Donato H, Krupenko NI, Davies C, Krupenko S: A: crystal structure of the C-terminal domain of rat 10’formyltetrahydrofolate dehydrogenase in complex with NADP. Biochemistry 2007, 46: 2917–2929. 10.1021/bi0619573
Sheikh S, Ni L, Hurley TD, Weiner H: The potential roles of the conserved amino acids in human liver mitochondrial aldehyde dehydrogenase. J Biol Chem 1997, 272(30):18817–18822. 10.1074/jbc.272.30.18817
Farres J, Wang TT, Cunningham SJ, Weiner H: Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. Biochemistry 1995, 34(8):2592–2598. 10.1021/bi00008a025
Wang X, Weiner H: Involvement of glutamate 268 in the active site of human liver mitochondrial aldehyde dehydrogenase as probed by site-directed mutagenesis. Biochemistry 1995, 34: 237–243. 10.1021/bi00001a028
We thank the staff at beam line BL17U at the Shanghai Synchrotron Radiation Facility for support with data collection. This work was supported by the National Natural Science Foundation of China (31070655) to L. Gu.
The authors declared that they have no competing interests.
JS carried out gene clone, protein purification, crystallization, data measurement of PnpE and PnpE-NAD. CZ performed oligonucleotide-directed mutagenesis and purification. JJZ carried out enzyme activity assays. TDW performed docking of substrate to PnpE. DYZ refined the structure of PnpE and PnpE-NAD. LCG conceived of the study and designed the experiments and prepared the manuscript. NYZ prepared the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.